PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.
PHASE3Not yet recruitingINTERVENTIONAL
Enrollment
96
Participants
Timeline
Start Date
July 1, 2024
Primary Completion Date
July 1, 2025
Study Completion Date
July 1, 2026
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG
Intestinal bacteria freeze-dried powder capsules
Oral healthy intestinal bacteria freeze-dried powder capsules, tid
All Listed Sponsors
lead
Yun-fei Xia
OTHER
NCT06486220 - PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial. | Biotech Hunter | Biotech Hunter